{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:35:24Z","timestamp":1772217324758,"version":"3.50.1"},"reference-count":84,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperlipidaemia is a major risk factor for cardiovascular morbidity and mortality. 3\u2010hydroxy\u20103\u2010methylglutaryl coenzyme\u2010A reductase inhibitors (\u2018statins\u2019) are first\u2010line therapies for hyperlipidaemia. For each 1.0 mmoL\/L reduction in low\u2010density lipoprotein (LDL)\u2010cholesterol, statins reduce the risk of major vascular events by 21% and all\u2010cause mortality by 9%. Owing to their clinical effectiveness and excellent safety profile, many Australians are prescribed statins. There has been widespread reporting of possible side\u2010effects, particularly muscle pains. Conversely, statin cessation relating to possible side\u2010effects exposes patients to increased risk of vascular events and death. Although there is clinical consensus for diagnosing rare side\u2010effects (e.g. myopathy or rhabdomyolysis), confirming that statins cause other less common side\u2010effects (e.g. memory impairment) is difficult as strong randomised trial evidence related to statins and non\u2010muscle\u2010related side\u2010effects is lacking. A stepwise approach to possible statin intolerance, consistent definitions and a simple flowchart may improve diagnosis and management. An increasing array of potential treatments is emerging, including intermittent statin dosing, new LDL\u2010lowering drugs, LDL apheresis and supplements. Optimal statin use and management of statin intolerance should improve cardiovascular care and clinical outcomes.<\/jats:p>","DOI":"10.1111\/imj.14429","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T05:17:40Z","timestamp":1568179060000},"page":"1081-1091","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Suggested clinical approach for the diagnosis and management of \u2018statin intolerance\u2019 with an emphasis on muscle\u2010related side\u2010effects"],"prefix":"10.1111","volume":"49","author":[{"given":"Anosh","family":"Sivashanmugarajah","sequence":"first","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre University of Sydney  Sydney New South Wales Australia"},{"name":"Department of Cardiology Royal Prince Alfred Hospital  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Fulcher","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre University of Sydney  Sydney New South Wales Australia"},{"name":"Department of Cardiology Royal Prince Alfred Hospital  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sullivan","sequence":"additional","affiliation":[{"name":"NSW Health Pathology Royal Prince Alfred Hospital  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Elam","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Tennessee  Knoxville Tennessee USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Jenkins","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre University of Sydney  Sydney New South Wales Australia"},{"name":"Department of Medicine University of Melbourne, St. Vincent's Hospital  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Keech","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre University of Sydney  Sydney New South Wales Australia"},{"name":"Department of Cardiology Royal Prince Alfred Hospital  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.11.010"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61368-4"},{"key":"e_1_2_16_4_1","unstructured":"Pharmaceutical Benefits Scheme. Expenditure and Prescriptions. Twelve Months to 30 June 2017. [cited 2019 Jul 30]. Available from URL:http:\/\/www.pbs.gov.au\/info\/statistics\/expenditure-prescriptions-twelve-months-to-30-june-2017"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.59938"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312782"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.07.752"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.937422"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2004.00299.x"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799504803"},{"key":"e_1_2_16_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2013.09.023"},{"key":"e_1_2_16_12_1","unstructured":"Australian Government: Department of Health. Therapeutic Goods Administration. [cited 2019 Jul 30]. Available from URL:https:\/\/www.tga.gov.au\/"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1996.tb04224.x"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050072"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2011.26.3.294"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2016.01.003"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/JES.0b013e31826c169e"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/0129784-200808060-00004"},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0365"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61965-6"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.860"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61190-8"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.042"},{"key":"e_1_2_16_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.10.053"},{"key":"e_1_2_16_25_1","unstructured":"MIMS Australia. [cited 2019 Jul 30]. Available from URL:http:\/\/www.mims.com.au\/"},{"key":"e_1_2_16_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-12-201306180-00004"},{"key":"e_1_2_16_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000034125.94759.41"},{"key":"e_1_2_16_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.121"},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2016.01.016"},{"key":"e_1_2_16_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31357-5"},{"key":"e_1_2_16_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600176"},{"key":"e_1_2_16_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181308"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.04.012"},{"key":"e_1_2_16_34_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.83a.14120"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K04-144"},{"key":"e_1_2_16_36_1","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.157251"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14341"},{"key":"e_1_2_16_38_1","unstructured":"Ministry of Health. Cardiovascular Disease Risk Assessment (New Zealand Primary Care Handbook 2012 updated 2013) [Cited 2019 Jul 30]. Available from URL:http:\/\/pro.healthmentoronline.com\/assets\/cardio-vascular-disease-risk-assessment-updated-2013-dec13.pdf"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604304"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-014-6546-5"},{"key":"e_1_2_16_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3409-3"},{"key":"e_1_2_16_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.10.043"},{"key":"e_1_2_16_43_1","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2014099"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043"},{"key":"e_1_2_16_45_1","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2015.49807"},{"key":"e_1_2_16_46_1","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0140-6736(17)31075-9","article-title":"Adverse events associated with unblended, but not with blinded, statin therapy in the Anglo\u2010Scandinavian Cardiac Outcomes Trial\u2010Lipid Lowering Arm (ASCOT\u2010LLA): a randomised double\u2010blind placebo\u2010controlled trial and its non\u2010randomised non\u2010blind extension phase","volume":"389","author":"Gupta A","year":"2017","journal-title":"Lancet"},{"key":"e_1_2_16_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00500"},{"key":"e_1_2_16_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.04.004"},{"key":"e_1_2_16_49_1","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2012-0118"},{"key":"e_1_2_16_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.04.026"},{"key":"e_1_2_16_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/2324709617709031"},{"key":"e_1_2_16_52_1","unstructured":"NPS MedicineWise. SAMS Management Algorithm; 2017 [cited 2019 Jul 30]. Available from URL:https:\/\/cdn2.scrvt.com\/08ab3606b0b7a8ea53fd0b40b1c44f86\/939f941da81483d0\/9e56a18edebf\/SAMS-Management-Algorithm.pdf"},{"key":"e_1_2_16_53_1","unstructured":"Heart Foundation. Position Statement. Phytosterol\/Stanol Enriched Foods. 2017 [cited 2019 Jul 30]. Available from URL:https:\/\/www.heartfoundation.org.au\/images\/uploads\/publications\/Heart_Foundation_Position_Statement_-_Phytosterolstanol_enriched_foods_2017.pdf"},{"key":"e_1_2_16_54_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-7-201304020-00004"},{"key":"e_1_2_16_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.06.004"},{"key":"e_1_2_16_56_1","doi-asserted-by":"publisher","DOI":"10.2337\/dcS13-2038"},{"key":"e_1_2_16_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2012.12.015"},{"key":"e_1_2_16_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.03.454"},{"key":"e_1_2_16_59_1","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2011.20597"},{"key":"e_1_2_16_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"key":"e_1_2_16_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802104-0.00015-9"},{"key":"e_1_2_16_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03340270029025"},{"key":"e_1_2_16_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000465"},{"key":"e_1_2_16_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60656-3"},{"key":"e_1_2_16_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318202709f"},{"key":"e_1_2_16_66_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.112.966168"},{"key":"e_1_2_16_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812792"},{"key":"e_1_2_16_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1814933"},{"key":"e_1_2_16_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1508120"},{"key":"e_1_2_16_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664"},{"key":"e_1_2_16_71_1","unstructured":"TokluB AmirianJ GiuglianoPR. Current Indications Cost and Clinical Use of Anti\u2010PCSK9 Monoclonal Antibodies. American College of Cardiology Expert Analysis; 2016 [cited 2019 Jul 30]. Available from URL:https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2016\/05\/18\/14\/34\/current-indications-cost-and-clinical-use-of-anti-pcsk9-monoclonal-antibodies"},{"key":"e_1_2_16_72_1","unstructured":"Pharmaceutical Benefits Scheme. Evolocumab. [cited 2019 Jul 30]. Available from URL:http:\/\/www.pbs.gov.au\/medicine\/item\/10958R-11193D"},{"key":"e_1_2_16_73_1","first-page":"864317","article-title":"Usefulness of lipid apheresis in the treatment of familial hypercholesterolaemia","volume":"2014","author":"Liu M","year":"2014","journal-title":"J Lipids"},{"key":"e_1_2_16_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.12.025"},{"key":"e_1_2_16_75_1","unstructured":"Esperion Therapeutics. Evaluation of Major Cardiovascular Events in Patients with or at High Risk for Cardiovascular Disease Who Are Statin\u2010Intolerant Treated with Bempedoic Acid (ETC\u20101002) or Placebo. [cited 2019 Jul 30]. Available from URL:https:\/\/ClinicalTrials.gov\/show\/NCT02993406"},{"key":"e_1_2_16_76_1","unstructured":"Esperion Therapeutics. Assessment of the Long\u2010Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE). [cited 2019 Jul 30]. Available from URL:https:\/\/ClinicalTrials.gov\/show\/NCT03067441"},{"key":"e_1_2_16_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.040"},{"key":"e_1_2_16_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.12.016"},{"key":"e_1_2_16_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.08.021"},{"key":"e_1_2_16_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12374"},{"key":"e_1_2_16_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2004.10719389"},{"key":"e_1_2_16_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2212-8"},{"key":"e_1_2_16_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2013.10.006"},{"key":"e_1_2_16_84_1","first-page":"1071","article-title":"Course of the progression of experimentally induced arteriosclerotic vessel wall changes after treatment with magnesium orotate","volume":"50","author":"Jellinek H","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_16_85_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu7095388"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.14429","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.14429","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.14429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T17:20:53Z","timestamp":1694193653000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.14429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1111\/imj.14429"],"URL":"https:\/\/doi.org\/10.1111\/imj.14429","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"2018-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}